Wells Fargo’s Hologic HOLX Stock Holding History

Wells Fargo’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-100	Closed	-$8K	–	7368
2021 Q4	$8K	Buy	+100	New	+$7.35K	﹤0.01%	6617

Other funds holding HOLX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Wells Fargo's HOLX Position: Q1 2026 in Review

Wells Fargo reduced its Hologic (HOLX) stake by 84% in Q1 2026, selling an estimated $35.7M and leaving 92,604 shares worth $7M. The position accounts for ﹤0.01% of the portfolio, ranked #2312.

Wells Fargo first reported a position in HOLX in Q2 2013 and has held it in 52 quarters since. The position peaked at $221M in Q4 2017. 704 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.

Wells Fargo held 92,604 shares of Hologic worth $7M as of Q1 2026.
Wells Fargo sold 475,224 Hologic shares in Q1 2026, an estimated $35.7M.
Hologic made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #2312 holding.
Wells Fargo first reported a position in Hologic in Q2 2013 and has held it in 52 quarters since.
Wells Fargo's Hologic position peaked at $221M in Q4 2017.
704 funds tracked by Wall St. Rank held Hologic as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.